PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
16-May-2024 SYMBICORT (budesonide/formoterol) TURBOHALER 200/6® ACCEPTED FOR USE IN SCOTLAND AS RELIEVER THERAPY FOR PATIENTS WITH MILD ASTHMA AGED 12 YEARS AND OLDER AstraZeneca
16-May-2024 Pharmanovia and Closed Loop Medicine launch the OptiZest study to investigate personalised dose management in hypertension Pharmanovia
15-May-2024 Significant and Sustained Improvements in Renal Function Reported for Adults with Chronic Hypoparathyroidism Treated with TransCon™ PTH (Palopegteriparatide): 2-year Results from Phase 3 PaTHway Trial Ascendis Pharma A/S
15-May-2024 HUTCHMED Initiates the RAPHAEL Registrational Phase III Trial of HMPL-306 for Patients with IDH1- and/or IDH2-Mutated Relapsed/Refractory Acute Myeloid Leukemia in China HUTCHMED
15-May-2024 HUTCHMED Initiates Phase II/III Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma in Collaboration with Hengrui HUTCHMED
15-May-2024 Publication in Nature Immunology outlining the contribution of B cells to anticancer immunosurveillance highlights Alchemab’s capabilities and potential to develop new cancer therapies Alchemab
15-May-2024 Integrated DNA Technologies and Molecular Health Ink Commercial Partnership Integrated DNA Technologies
13-May-2024 Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification Sartorius
13-May-2024 Breakthrough in Cancer Care After Entia Gets Go-Ahead for World’s First At-Home Blood Monitoring Solution for Patients Entia
13-May-2024 Maria Alfaiate appointed new Executive Vice President Commercial and Corporate Strategy at Lundbeck H. Lundbeck A/S
13-May-2024 Macomics and IFOM (the AIRC Institute of Molecular Oncology) Announce Macrophage Scientific Collaboration Macomics Ltd
13-May-2024 SYMBICORT (budesonide/formoterol) TURBOHALER 200/6® ACCEPTED FOR USE IN SCOTLAND AS RELIEVER THERAPY FOR PATIENTS WITH MILD ASTHMA AGED 12 YEARS AND OLDER AstraZeneca
13-May-2024 Research shows that ‘softer’ proteins can cross into the nucleus quicker The Francis Crick Institute
10-May-2024 MODERNA WELCOMES THE SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE TO THE MODERNA INNOVATION AND TECHNOLOGY CENTRE IN OXFORDSHIRE Moderna
10-May-2024 New EU directive will require UK businesses trading with the EU to enforce ESG compliance within their supply chains INVERTO
10-May-2024 Bloomsbury Genetic Therapies showcases its First Preclinical Data on Parkinson’s Disease Program at the American Society of Gene & Cell Therapy 2024 Annual Meeting Bloomsbury Genetic Therapies Limited
10-May-2024 Commit Biologics launches with €16m seed financing to pioneer complement system activation to treat cancer and autoimmune disease Commit Biologics
09-May-2024 EDWARDS LAUNCHES THE SAPIEN 3 ULTRA RESILIA VALVE WITH TECHNOLOGY TO ENHANCE DURABILITY Edwards Lifesciences
09-May-2024 PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting PureTech Health plc
09-May-2024 Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024 Nxera Pharma